(Q36053896)

11 August 2017

The effect of dosing regimen on the pharmacokinetics of risedronate (English)

1 reference

11 August 2017

1 reference

D Y Mitchell

1

1 reference

11 August 2017

M A Heise

2

1 reference

11 August 2017

K A Pallone

3

1 reference

11 August 2017

M E Clay

4

1 reference

11 August 2017

J D Nesbitt

5

1 reference

11 August 2017

D A Russell

6

1 reference

11 August 2017

C W Melson

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

48

1 reference

11 August 2017

4

1 reference

11 August 2017

536-542

1 reference

Evaluation of orally administered highly variable drugs and drug formulations

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Bisphosphonates: a review of their pharmacokinetic properties

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Urinary excretion of aminohydroxypropylidene bisphosphonate in cancer patients after single intravenous infusions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Bisphosphonates in the treatment of metabolic bone diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Sources of data for developing and maintaining a nutrient database

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Studies of the oral bioavailability of alendronate.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Statistical estimations in pharmacokinetics.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Absorption of oral diphosphonate in normal subjects

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014385

Clodronate kinetics and bioavailability

23 September 2018

1 reference

12 December 2020

Pharmacokinetics of clodronate in patients with metastatic breast cancer

1 reference

12 December 2020

Antiresorptive dose-response relationships across three generations of bisphosphonates

1 reference

12 December 2020

Clinical pharmacology of alendronate sodium

1 reference

12 December 2020

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

12 December 2020

Paget's disease of bone: reduction of disease activity with oral risedronate

1 reference

12 December 2020

Risedronate gastrointestinal absorption is independent of site and rate of administration

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00035.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10583024

1 reference